What one share of Merck & Co. holds
Merck & Co., Inc. (Merck or the Company) is a global health care company that delivers innovative health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. The Company’s operations are principally managed on a product basis and include two operating segments, Pharmaceutical and Animal Health, both of which are reportable segments.
Merck & Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $26.82 |
|---|---|
| Profit | $1.28 |
| Capex (buildings and equipment) | $1.57 |
| Free cash flow | $6.47 |
| Dividends | $3.36 |
| Cash and investments | $3.39 |
| Debt | $21.83 |
| Book value | $16.99 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2007 | $11.01 | $1.49 | $0.46 | $2.72 | $1.52 | $9.37 |
| 2008 | $11.13 | $3.63 | $0.61 | $2.46 | $1.52 | $7.71 |
| 2009 | $12.07 | $5.65 | $0.64 | $0.85 | $1.52 | $19.00 |
| 2010 | $14.74 | $0.28 | $0.54 | $2.93 | $1.52 | $17.64 |
| 2011 | $15.53 | $2.02 | $0.56 | $3.45 | $1.56 | $17.93 |
| 2012 | $15.37 | $2.00 | $0.64 | $2.62 | $1.69 | $17.52 |
| 2013 | $14.70 | $1.47 | $0.52 | $3.37 | $1.73 | $17.00 |
| 2014 | $14.43 | $4.07 | $0.45 | $2.28 | $1.77 | $17.14 |
| 2015 | $13.90 | $1.56 | $0.45 | $3.96 | $1.81 | $16.06 |
| 2016 | $14.28 | $1.41 | $0.58 | $3.14 | $1.85 | $14.58 |
| 2017 | $14.60 | $0.87 | $0.69 | $1.66 | $1.89 | $12.73 |
| 2018 | $15.79 | $2.32 | $0.98 | $3.10 | $1.99 | $10.30 |
| 2019 | $15.16 | $3.82 | $1.31 | $3.90 | $2.26 | $10.20 |
| 2020 | $16.34 | $2.78 | $1.74 | $2.29 | $2.48 | $10.01 |
| 2021 | $19.19 | $5.14 | $1.75 | $3.42 | $2.64 | $15.11 |
| 2022 | $23.32 | $5.71 | $1.73 | $5.79 | $2.80 | $18.12 |
| 2023 | $23.60 | $0.14 | $1.52 | $3.59 | $2.96 | $14.84 |
| 2024 | $25.25 | $6.74 | $1.33 | $7.12 | $3.12 | $18.32 |
| 2025 | $25.93 | $7.28 | $1.64 | $4.93 | $3.28 | $21.26 |
Common questions about Merck & Co.
How much does one share of Merck & Co. earn?
Over the last 12 months, each share of Merck & Co. earned $1.28 of profit on $26.82 of sales, keeping about 5¢ of every $1 (profit margin).
Does Merck & Co. pay a dividend?
Yes. Merck & Co. paid $3.36 per share in dividends over the last 12 months, and it paid a dividend in every year from 2007 to 2025 in StockSlicer’s data. That’s about 263¢ of each $1 of profit (payout ratio).
What is Merck & Co.’s book value per share?
Merck & Co.’s book value is $16.99 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Merck & Co. have?
Each share of Merck & Co. has $3.39 of cash and investments and $21.83 of debt, as of June 30, 2026.
What is Merck & Co.’s free cash flow per share?
$6.47 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
How has Merck & Co.’s profit per share changed over time?
Profit per share went from $1.49 in 2007 to $7.28 in 2025, growing about 9.2% a year (adjusted for stock splits).
Has Merck & Co. bought back shares?
Merck & Co.’s share count rose about 14% from 2007 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.